121 related articles for article (PubMed ID: 11071272)
1. Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr/lpr mice.
Keng T; Privalle CT; Gilkeson GS; Weinberg JB
Mol Med; 2000 Sep; 6(9):779-92. PubMed ID: 11071272
[TBL] [Abstract][Full Text] [Related]
2. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.
Weinberg JB; Granger DL; Pisetsky DS; Seldin MF; Misukonis MA; Mason SN; Pippen AM; Ruiz P; Wood ER; Gilkeson GS
J Exp Med; 1994 Feb; 179(2):651-60. PubMed ID: 7507509
[TBL] [Abstract][Full Text] [Related]
3. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2.
Gilkeson GS; Mudgett JS; Seldin MF; Ruiz P; Alexander AA; Misukonis MA; Pisetsky DS; Weinberg JB
J Exp Med; 1997 Aug; 186(3):365-73. PubMed ID: 9236188
[TBL] [Abstract][Full Text] [Related]
4. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.
Weinberg JB
Environ Health Perspect; 1998 Oct; 106 Suppl 5(Suppl 5):1131-7. PubMed ID: 9788887
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice.
Oates JC; Gilkeson GS
J Investig Med; 2004 Jan; 52(1):62-71. PubMed ID: 14989372
[TBL] [Abstract][Full Text] [Related]
7. Effect of late modulation of nitric oxide production on murine lupus.
Oates JC; Ruiz P; Alexander A; Pippen AM; Gilkeson GS
Clin Immunol Immunopathol; 1997 Apr; 83(1):86-92. PubMed ID: 9073540
[TBL] [Abstract][Full Text] [Related]
8. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
[TBL] [Abstract][Full Text] [Related]
9. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
[TBL] [Abstract][Full Text] [Related]
10. Genotype effects on the antioxidant enzymes activity and mRNA expression in liver and kidney tissues of autoimmune-prone MRL/MpJ-lpr/lpr mice.
Venkatraman JT; Chandrasekar B; Kim JD; Fernandes G
Biochim Biophys Acta; 1994 Jul; 1213(2):167-75. PubMed ID: 8025127
[TBL] [Abstract][Full Text] [Related]
11. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids.
van der Veen RC; Roberts LJ
J Neuroimmunol; 1999 Mar; 95(1-2):1-7. PubMed ID: 10229110
[TBL] [Abstract][Full Text] [Related]
12. Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL-lpr/lpr mice.
Weinberg JB; Gilkeson GS; Mason RP; Chamulitrat W
Free Radic Biol Med; 1998 Jan; 24(1):191-6. PubMed ID: 9436630
[TBL] [Abstract][Full Text] [Related]
13. Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL/Mp-lpr/lpr mice.
Hortelano S; Díaz-Guerra MJ; Gonzalez-García A; Leonardo E; Gamallo C; Boscá L; Martínez-A C
J Immunol; 1997 Feb; 158(3):1402-8. PubMed ID: 9013985
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice.
Goulet JL; Griffiths RC; Ruiz P; Spurney RF; Pisetsky DS; Koller BH; Coffman TM
J Immunol; 1999 Jul; 163(1):359-66. PubMed ID: 10384136
[TBL] [Abstract][Full Text] [Related]
17. DNA damage in arsenite- and cadmium-treated bovine aortic endothelial cells.
Liu F; Jan KY
Free Radic Biol Med; 2000 Jan; 28(1):55-63. PubMed ID: 10656291
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation.
Moulian N; Truffault F; Gaudry-Talarmain YM; Serraf A; Berrih-Aknin S
Blood; 2001 Jun; 97(11):3521-30. PubMed ID: 11369646
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MIP-1alpha-induced human neutrophil and monocyte chemotactic activity by reactive oxygen and nitrogen metabolites.
Sato E; Simpson KL; Grisham MB; Koyama S; Robbins RA
J Lab Clin Med; 2000 Feb; 135(2):161-9. PubMed ID: 10695661
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
